|
1
|
Schmidt D and Kuwert T: Hybrid molecular
imaging in differentiated thyroid carcinoma. Front Horm Res.
45:37–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grewal RK, Ho A and Schöder H: Novel
approaches to thyroid cancer treatment and response assessment.
Semin Nucl Med. 46:109–118. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nixon IJ: Well-differentiated thyroid
cancer-are you overtreating your patients? Endokrynol Pol.
67:60–66. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frampton JE: Lenvatinib: A review in
refractory thyroid cancer. Target Oncol. 11:115–122. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Williams D: Thyroid growth and cancer. Eur
Thyroid J. 4:164–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schmid D, Ricci C, Behrens G and Leitzmann
MF: Adiposity and risk of thyroid cancer: A systematic review and
meta-analysis. Obes Rev. 16:1042–1054. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bae YJ, Schaab M and Kratzsch J:
Calcitonin as biomarker for the medullary thyroid carcinoma. Recent
Results Cancer Res. 204:117–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Patmanathan SN, Wang W, Yap LF, Herr DR
and Paterson IC: Mechanisms of sphingosine 1-phosphate receptor
signalling in cancer. Cell Signal. 34:66–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farez MF and Correale J: Sphingosine
1-phosphate signaling in astrocytes: Implications for progressive
multiple sclerosis. J Neurol Sci. 361:60–65. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guerrero M, Urbano M and Roberts E:
Sphingosine 1-phosphate receptor 1 agonists: A patent review
(2013–2015). Expert Opin Ther Pat. 26:455–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kwong E, Li Y, Hylemon PB and Zhou H: Bile
acids and sphingosine-1-phosphate receptor 2 in hepatic lipid
metabolism. Acta Pharm Sin B. 5:151–157. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sanllehí P, Abad JL, Casas J and Delgado
A: Inhibitors of sphingosine-1-phosphate metabolism (sphingosine
kinases and sphingosine-1-phosphate lyase). Chem Phys Lipids.
197:69–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Furuya H, Shimizu Y, Tamashiro PM, Iino K,
Bielawski J, Chan OTM, Pagano I and Kawamori T: Sphingosine kinase
1 expression enhances colon tumor growth. J Transl Med. 15:1202017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang LS and Natarajan V: Sphingolipids in
pulmonary fibrosis. Adv Biol Regul. 57:55–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu PH, Chen MB, Liu YY, Wu MH, Li WT, Wei
MX, Liu CY and Qin SK: Identification of sphingosine kinase 1
(SphK1) as a primary target of icaritin in hepatocellular carcinoma
cells. Oncotarget. 8:22800–22810. 2017.PubMed/NCBI
|
|
16
|
Li S, Zhou Y, Zheng X, Wu X, Liang Y, Wang
S and Zhang Y: Sphk1 promotes breast epithelial cell proliferation
via NF-κB-p65-mediated cyclin D1 expression. Oncotarget.
7:80579–80585. 2016.PubMed/NCBI
|
|
17
|
Fan Z, Jiang H, Wang Z and Qu J:
Atorvastatin partially inhibits the epithelial-mesenchymal
transition in A549 cells induced by TGF-β1 by attenuating the
upregulation of SphK1. Oncol Rep. 36:1016–1022. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang W, Xie Z, Cui W, Guo Y, Xu L, Wu J
and Guan H: Comprehensive gene and microRNA expression profiling
reveals a role for miRNAs in the oncogenic roles of SphK1 in
papillary thyroid cancer. J Cancer Res Clin Oncol. 143:601–611.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guan H, Liu L, Cai J, Liu J, Ye C, Li M
and Li Y: Sphingosine kinase 1 is overexpressed and promotes
proliferation in human thyroid cancer. Mol Endocrinol.
25:1858–1866. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murakami M, Ichihara M, Sobue S, Kikuchi
R, Ito H, Kimura A, Iwasaki T, Takagi A, Kojima T, Takahashi M, et
al: RET signaling-induced SPHK1 gene expression plays a role in
both GDNF-induced differentiation and MEN2-type oncogenesis. J
Neurochem. 102:1585–1594. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brünnert D, Sztachelska M, Bornkessel F,
Treder N, Wolczynski S, Goyal P and Zygmunt M: Lysophosphatidic
acid and sphingosine 1-phosphate metabolic pathways and their
receptors are differentially regulated during decidualization of
human endometrial stromal cells. Mol Hum Reprod. 20:1016–1025.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Datta A, Loo SY, Huang B, Wong L, Tan SS,
Tan TZ, Lee SC, Thiery JP, Lim YC, Yong WP, et al: SPHK1 regulates
proliferation and survival responses in triple-negative breast
cancer. Oncotarget. 5:5920–5933. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ribeiro FR, Meireles AM, Rocha AS and
Teixeira MR: Conventional and molecular cytogenetics of human
non-medullary thyroid carcinoma: Characterization of eight cell
line models and review of the literature on clinical samples. BMC
Cancer. 8:3712008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakamura T, Matsuyama N, Kirino M, Kasai
M, Kiyohara S and Ikenaga T: Distribution, innervation, and
cellular organization of taste buds in the sea catfish, plotosus
japonicus. Brain Behav Evol. 89:209–218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Selvam Panneer S, De Palma RM, Oaks JJ,
Oleinik N, Peterson YK, Stahelin RV, Skordalakes E, Ponnusamy S,
Garrett-Mayer E, Smith CD and Ogretmen B: Binding of the
sphingolipid S1P to hTERT stabilizes telomerase at the nuclear
periphery by allosterically mimicking protein phosphorylation. Sci
Signal. 8:ra582015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu H, Ma Y, He HW, Zhao WL and Shao RG:
SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal
transition by promoting the autophagy-linked lysosomal degradation
of CDH1/E-cadherin in hepatoma cells. Autophagy. 13:900–913. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sukocheva O, Wadham C, Gamble J and Xia P:
Sphingosine-1-phosphate receptor 1 transmits estrogens' effects in
endothelial cells. Steroids. 104:237–245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu Y, Dong B, Huang J, Kong W, Xue W, Zhu
Y, Zhang J and Huang Y: Sphingosine kinase 1 is overexpressed and
promotes adrenocortical carcinoma progression. Oncotarget.
7:3233–3244. 2016.PubMed/NCBI
|
|
30
|
Okada T, Ding G, Sonoda H, Kajimoto T,
Haga Y, Khosrowbeygi A, Gao S, Miwa N, Jahangeer S and Nakamura S:
Involvement of N-terminal-extended form of sphingosine kinase 2 in
serum-dependent regulation of cell proliferation and apoptosis. J
Biol Chem. 280:36318–36325. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Z, Yan Z, Yuan Z, Sun Y, He H and
Mai C: SPHK1 inhibitor suppresses cell proliferation and invasion
associated with the inhibition of NF-κB pathway in hepatocellular
carcinoma. Tumour Biol. 36:1503–1509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsukamoto S, Huang Y, Kumazoe M, Lesnick
C, Yamada S, Ueda N, Suzuki T, Yamashita S, Kim YH, Fujimura Y, et
al: Sphingosine kinase-1 protects multiple myeloma from apoptosis
driven by cancer-specific inhibition of RTKs. Mol Cancer Ther.
14:2303–2312. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu H, Duan P, Zhu H and Rao D: miR-613
inhibits bladder cancer proliferation and migration through
targeting SphK1. Am J Transl Res. 9:1213–1221. 2017.PubMed/NCBI
|
|
34
|
Zhang S, Deng Z, Yao C, Huang P, Zhang Y,
Cao S and Li X: AT7867 inhibits human colorectal cancer cells via
AKT-Dependent and AKT-Independent mechanisms. PLoS One.
12:e01695852017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li W, Li J, Wang Y, Zhang K, Li N, Tian Z,
Ni B, Wang H and Ruan Z: Sphingosine kinase 1 is a potential
therapeutic target for nasopharyngeal carcinoma. Oncotarget.
7:80586–80598. 2016.PubMed/NCBI
|
|
36
|
Zhu P, Liao LY, Zhao TT, Mo XM, Chen GG
and Liu ZM: GPER/ERK&;AKT/NF-κB pathway is involved in
cadmium-induced proliferation, invasion and migration of
GPER-positive thyroid cancer cells. Mol Cell Endocrinol. 442:68–80.
2017. View Article : Google Scholar : PubMed/NCBI
|
